Search Results

Nationwide study of eculizumab in paroxysmal nocturnal hemoglobinuria: Evaluation of treatment indications and outcomes.

• Authors : Schaap, Charlotte C. M. (AUTHOR); Heubel‐Moenen, Floor C. J. I. (AUTHOR); Nur, Erfan (AUTHOR)

Subjects: PAROXYSMAL hemoglobinuria; ECULIZUMAB; TREATMENT effectivenessNETHERLANDS

• Source: European Journal of Haematology. Jun2023, Vol. 110 Issue 6, p648-658. 11p.

Record details

Response to: Eculizumab use throughout pregnancy in two patients with aquaporin‐4‐positive neuromyelitis optica spectrum disorder.

• Authors : Kister, Ilya¹ (AUTHOR); Wilson, Alla^1,2 (AUTHOR)

Subjects: *NEUROMYELITIS optica; *ECULIZUMAB; *PREGNANCY

• Source: Clinical & Experimental Neuroimmunology. Jul2024, p1. 2p.

Record details

Long‐term outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in a real‐world setting.

• Authors : Versmold, Katharina (AUTHOR); Alashkar, Ferras (AUTHOR); Raiser, Carina (AUTHOR)

Subjects: PAROXYSMAL hemoglobinuria; ECULIZUMAB; LACTATE dehydrogenaseESSEN (Germany)

• Source: European Journal of Haematology. Jul2023, Vol. 111 Issue 1, p84-95. 12p.

Record details

Long-term effectiveness of eculizumab: Data from the International PNH Registry.

• Authors : Terriou, Louis; Jong Wook Lee; Forsyth, Cecily

Subjects: PAROXYSMAL hemoglobinuria; ECULIZUMAB; PROPORTIONAL hazards models

• Source: European Journal of Haematology. Nov2023, Vol. 111 Issue 5, p796-804. 9p.

Record details

Real‐world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis.

• Authors : Tokuyasu, Daiki; Suzuki, Shigeaki; Uzawa, Akiyuki

Subjects: MYASTHENIA gravis; ECULIZUMAB; CLINICAL trialsJAPAN

• Source: Annals of Clinical & Translational Neurology; May2024, Vol. 11 Issue 5, p1338-1346, 9p

Record details

Invited commentary.

Subjects: *ECULIZUMAB; *BLOOD group antigens; *HEART transplantation

• Source: Xenotransplantation. Jan2022, Vol. 29 Issue 1, p1-2. 2p.

Record details

Long-term remission with eculizumab in atypical haemolytic uraemic syndrome.

• Authors : Carter, Simon¹; Hewitt, Ian²; Kausman, Joshua^1,3,4

Subjects: *ECULIZUMAB; *HEMOLYTIC-uremic syndrome treatment; *KIDNEY function tests

• Source: Nephrology. Feb2017 Supplement, Vol. 22, p7-10. 4p.

Record details

Eculizumab for paroxysmal nocturnal hemoglobinuria: Two cases of successful pregnancy outcomes.

• Authors : Ilic, Jovanka; Pujic, Borislava; Jakovljevic, Branislava

Subjects: PREGNANCY outcomes; PAROXYSMAL hemoglobinuria; HIGH-risk pregnancy

• Source: Clinical Case Reports; May2024, Vol. 12 Issue 5, p1-6, 6p

Record details

Subclinical atypical haemolytic uremic syndrome relapse following discontinuation of eculizumab.

• Authors : Choo, Shi Zhou¹; Brown, Fiona¹

Subjects: *HEMOLYTIC-uremic syndrome treatment; *ECULIZUMAB; *VEROCYTOTOXINS

• Source: Nephrology. Feb2017 Supplement, Vol. 22, p4-6. 3p.

Record details

Life-threatening pregnancy-associated atypical haemolytic uraemic syndrome and its response to eculizumab.

• Authors : Gately, Ryan¹; San, Aye¹; Kurtkoti, Jagadeesh¹

Subjects: *HEMOLYTIC-uremic syndrome diagnosis; *ECULIZUMAB; *KIDNEY function tests

• Source: Nephrology. Feb2017 Supplement, Vol. 22, p32-35. 4p.

Record details